Cadila Healthcare surges with arm receiving approval from USFDA for Ranitidine Injection

11 Dec 2018 Evaluate

Cadila Healthcare is currently trading at Rs. 344.65, up by 3.60 points or 1.06% from its previous closing of Rs. 341.05 on the BSE.

The scrip opened at Rs. 339.00 and has touched a high and low of Rs. 346.50 and Rs. 336.60 respectively. So far 39720 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 456.10 on 08-Jan-2018 and a 52 week low of Rs. 330.65 on 26-Oct-2018.

Last one week high and low of the scrip stood at Rs. 363.20 and Rs. 336.60 respectively. The current market cap of the company is Rs. 35293.53 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.34% and 7.87% respectively.

Cadila Healthcare’s wholly-owned subsidiary -- Liva Pharmaceuticals has received the approval from the US Food and Drug Administration (USFDA) for its supplemental abbreviated new drug application (ANDA), Ranitidine Injection USP, 25 mg/mL, 2 mL Single dose vials and 6 mL Multi-dose vials. It will be manufactured at Liva Pharma’s manufacturing facility at Vadodara in the state of Gujarat and is the first product to be approved from this site for marketing in the US.

Ranitidine belongs to the class of medications called H2-antagonists and is used to treat stomach and duodenal (intestinal) ulcers, and prevent them from recurring. It is also used to treat gastroesophageal reflux disease (GERD) and Zollinger-Ellison Syndrome. The injectable form of ranitidine is given for short-term treatment of these conditions when a patient is unable to take this medication orally.

The group now has 237 approvals and has so far filed over 340 ANDAs since the commencement of the filing process in FY 2003-04.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×